www.headway.coHealthcare / Digital HealthFounded: 2018Funding to Date: $406.42MM
Headway, founded in 2017, is a mental healthcare software-enabled network striving to remove historic barriers faced by mental health providers, payers, and patients. The company aims to connects patients with therapists who accept insurance, helping providers to expand their practices, and with the goal of finding a therapist they can afford. Headway is headquartered in New York, New York.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
08/29/2024 | Series D-2 | $30.02MM | $xx.xx | $2.38B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,500,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
08/29/2024 | Series D-1 | $50.44MM | $xx.xx | $2.38B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,200,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
07/23/2024 | Series D | $100MM | $xx.xx | $2.3B | Spark Capital, Thrive Capital, Andreessen Horowitz, Accel, Forerunner Ventures | |
Price per Share
$xx.xx
Shares Outstanding
8,326,868
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Spark Capital, Thrive Capital, Andreessen Horowitz, Accel, Forerunner Ventures
|
||||||
10/05/2023 | Series C | $125MM | $xx.xx | $1B | Spark Capital, Thrive Capital, Andreessen Horowitz, Accel | |
Price per Share
$xx.xx
Shares Outstanding
19,828,554
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Spark Capital, Thrive Capital, Andreessen Horowitz, Accel
|
||||||
05/04/2021 | Series B-1 | $6.03MM | $xx.xx | $754.72MM | Andreessen Horowitz, Thrive, GV, Accel Partners | |
Price per Share
$xx.xx
Shares Outstanding
1,059,760
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Andreessen Horowitz, Thrive, GV, Accel Partners
|
||||||
05/04/2021 | Series B | $63.26MM | $xx.xx | $754.72MM | Andreessen Horowitz, Thrive, GV, Accel Partners | |
Price per Share
$xx.xx
Shares Outstanding
11,114,752
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Andreessen Horowitz, Thrive, GV, Accel Partners
|
||||||
11/18/2020 | Series A | $25.37MM | $xx.xx | $120.37MM | Thrive, GV, Accel Partners, GFC, IA Ventures, Flatiron Health, Clover Health | |
Price per Share
$xx.xx
Shares Outstanding
26,292,792
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Thrive, GV, Accel Partners, GFC, IA Ventures, Flatiron Health, Clover Health
|
||||||
07/11/2019 | Series Seed-2 | $4.5MM | $xx.xx | $19.35MM | Accel Partners | |
Price per Share
$xx.xx
Shares Outstanding
20,588,828
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Accel Partners
|
||||||
09/10/2018 | Series Seed | $1.79MM | $xx.xx | $7.17MM | The Fund | |
Price per Share
$xx.xx
Shares Outstanding
14,831,620
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
The Fund
|